Document is current
Any future updates will be listed below
-
Authors
Cirkel, Anna
Göbel, Hartmut
Göbel, Carl
Alkatout, Ibrahim
Kaiser, Antonia
Brüggemann, Norbert
Minnerup, Jens
Rody, Achim
Cirkel, Christoph
-
Funding
Funding for this research was provided by:
Universität zu Lübeck
- License Information
-
More Information
Article History
Received: 7 April 2025
Accepted: 6 February 2026
First Online: 13 February 2026
Declarations
:
: Ethics approval for this study was issued by the ethics committee of University of Lübeck (AZ2023-287) prior to recruitment on 27.03.2023. Research was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all subjects regarding study participation and anonymized data storage before starting the survey.
: Not applicable.
: CC, CG, IA; KK, NB, JM, AC declare no competing interests; HG declares that he has received grants and honoraria for lectures from Abbvie, Allergan, Amgen, Bayer Vital, Berlin-Chemie, Bionorica, Eli Lilly, Grünenthal, Hormosan, Ipsen-Pharma, Janssen-Cilag, Johnson & Johnson, Klosterfrau, Lundbeck, Menarini Pharma, Mundipharma, MSD, Novartis, St. Jude Medical, Teva; AR declares that he has received lecture and consulting honoraria, as well as support for attending meetings and travel support from Roche, Daiichi Sankyo, Astra Zeneca, Pfizer, Novartis, Celgen, Novartis, ExactSciences, MSD, Pierre Fabre, Lilly, Seagen, Targos, Hexal.
